Top Industry Leaders in the Malabsorption Syndrome Market
Latest Malabsorption Syndrome Companies Updates:
Bio-Techne Corporation Launched the DuoCheck™ Celiac IgA/IgG Rapid Test Kit, offering a portable and rapid test for celiac disease, a common cause of malabsorption.
Exact Sciences Corporation Received FDA approval for its Cologuard® 4.0 MR colon cancer screening test, which can also detect DNA markers for certain causes of malabsorption like Lynch syndrome.
GenMark Diagnostics, Inc. Developed the ePlex® Gastrointestinal Pathogen Panel Plus (GPP+), an advanced multiplex PCR test panel identifying various infectious causes of malabsorption.
Takeda Pharmaceutical Company Limited Received FDA approval for Entyvio® (vedolizumab), a biologic medication for treating ulcerative colitis, a condition that can lead to malabsorption.
Nestlé Health Science (NHS) Introduced Peptamen® AF Complete Nutrition with Fiber, a nutrition formula intended for individuals with digestive issues and potential malabsorption concerns.
List of Malabsorption Syndrome Key companies in the market:
- Abbvie Inc.
- AstraZeneca PLC
- DSM
- Gilead Sciences
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals Inc.
- McNeil Nutritionals
- Perrigo
- Roche
- Vetbiochem India Private Limited
- Actelion Pharmaceuticals Ltd